Skip to main content
Premium Trial:

Request an Annual Quote

Sionex Raises $12.8M in Series B Financing

NEW YORK, Nov. 20 (GenomeWeb News) - Sionex, which is commercializing chemical sensor chips for biopharmaceutical and other applications, raised $12.8 million in a Series B round of funding, the company said today.

 

The funding was led by Morgenthaler Ventures, with additional funds from Rho Ventures and Navigator Technology Ventures, which are existing investors in the Waltham, Mass., company.

 

The company plans to use the capital to further develop and manufacture its products, and to expand  partnerships. In October, Sionex signed a deal with Varian to incorporate its microDMx technology into Varian's gas chromatography products. The company is also positioning its sensor technology as applicable to detection of chemical and biological agents for defense and homeland security applications, and to the biopharmaceutical, environmental, commercial, and diagnostic applications.

 

Sionex's microDMx technology is based on the technique of Field Asymetric Ion Mobility Spectrometry, or FAIMS, and its microfabrication in a MEMS format.

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.